Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.

Tazobactam (YTR-830H), a novel beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam for enhancement of the activity of piperacillin against beta-lactamase-producing, piperacillin-resistant clinical isolates. Piperacillin MICs were determined in media containing a fixed concentra...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	Kuck, N A, Jacobus, N V, Petersen, P J, Weiss, W J, Testa, R T
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1989
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172796/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2558615/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.11.1964
Oznake:	Označite Brez oznak, prvi označite!